Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-RUPATADINE DIN 02553155

Status: Marketed
Holder: APOTEX INC
Molecule: RUPATADINE (RUPATADINE FUMARATE)
Available to quote

Health Canada record

Active ingredient(s)RUPATADINE (RUPATADINE FUMARATE) 10 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCR06AX28 RUPATADINE
Original market date21-Jan-2025
Current status date21-Jan-2025
SourceHealth Canada DPD

Establishment licence of the holder

Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing RUPATADINE (RUPATADINE FUMARATE)

DINProductCompanyFormStrengthStatus
02552604PMS-RUPATADINEPHARMASCIENCE INCTabletRUPATADINE (RUPATADINE FUMARATE) 10 MGMarketed
02560119RIVA-RUPATADINELABORATOIRE RIVA INC.TabletRUPATADINE (RUPATADINE FUMARATE) 10 MGMarketed
02456451RUPALLMEDEXUS PHARMACEUTICALS INC.TabletRUPATADINE (RUPATADINE FUMARATE) 10 MGMarketed
02456478RUPALLMEDEXUS PHARMACEUTICALS INC.SolutionRUPATADINE (RUPATADINE FUMARATE) 1 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
347112025-01-21Abbreviated New Drug Submission (ANDS)
Request a quote for APO-RUPATADINE

How to read a Canadian DIN record